基于纳米颗粒的药物输送系统的进展,以改善质母细胞瘤治疗:解决挑战和调查机会
Md Ataur Rahman1, Maroua Jalouli2, Mahesh Kumar Yadab1
1Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA.
Cancers
|February 26, 2025
概括
纳米颗粒通过改善药物输送提供了一种有前途的方法来治疗多形质母细胞瘤 (GBM) 脑瘤. 本综述探讨了各种纳米粒子类型及其增强GBM治疗和克服治疗挑战的潜力.
科学领域:
- 纳米医学是一种纳米医学.
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 多形质母细胞瘤 (GBM) 是一种具有有限治疗选择的侵袭性脑瘤.
- 目前的治疗方法 (手术,放射,化疗) 有显著的副作用和有限的疗效.
- 基于纳米粒子的药物输送提供了一种新的策略,以改善GBM治疗结果.
研究的目的:
- 审查各种纳米颗粒在质母细胞瘤多种治疗中的应用.
- 分析不同类型纳米粒子的特性和治疗潜力.
- 讨论转化纳米粒子技术用于GBM治疗的进展和挑战.
主要方法:
- 对用于GBM治疗的纳米颗粒现有文献的审查.
- 基于脂质,聚合物和金属纳米颗粒的分析.
- 检查纳米粒子机制来增强药物输送 (BBB透,准,控制释放).
主要成果:
- 基于脂质的纳米颗粒 (脂质体,SLN) 改善了不溶性药物的输送.
- 聚合物纳米粒子提供受控释放和有针对性的交付.
- 金属纳米粒子显示了联合治疗和成像的潜力.
- 纳米粒子增强了血脑屏障的透和瘤向.
结论:
- 纳米粒子代表了GBM药物输送的重大进步.
- 需要进一步的研究和临床试验来克服临床翻译的障碍.
- 纳米技术对改善多形质母细胞瘤治疗疗效和患者预后有很大的前景.
更多相关视频
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
1.6K
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
2.4K
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
